Risk of viral transmission in a non-human primate model of HIV infection is reduced substantially by cloaking immune cells with antibodies that block T cell trafficking to the gut, report scientists. The findings suggest that drugs that are already in clinical trials for inflammatory bowel diseases might be effective in the treatment or prevention of HIV infection. The results are scheduled for publication in iNature Medicine/i. "We were surprised by the effects ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment